An investigation as to why some patients with Sjogren-Larsson Syndrome (SLS) have severe symptoms and some have mild symptoms. SLS is a genetic disorder of fatty alcohol metabolism due to a faulty gene that is responsible for the metabolism of fatty aldehydes and fatty alcohol. Symptoms resulting form this syndrome are scaling skin, developmental delay, spasticity, mental retardation, and inability to walk. Patients survive well into adulthood. The accumulation of the unmetabolized fat is thought to cause the symptoms. The purpose of this study is to determine whether and to what extent the symptoms of SLS are effected by variation in the metabolism of fatty alcohol and in the dietary intake of this fat. This study will consist of two parts. Patients with SLS may be enrolled in both parts and normal volunteers will be enrolled only in the second part. SLS patients will be admitted to the General Clinical Research Center for three days during which they will be given a physical to determine the makeup of the body. Photographs will be taken of the skin problems. The eyes will be examined for glistening, white spots. A brain MRI (magnetic resonance imaging) will be done to determine brain disease. A skin biopsy will be performed. Blood samples will be taken to measure fatty alcohol accumulation. Instructions will be given on how to record a dietary history at home. Types and amounts of food will be recorded. In part 2, adult SLS and normal subjects will be included. It will take three days and subjects will be given a type of fatty alcohol to drink. After an overnight fast, fluids and sugar will be given intravenously for eight hours. Fasting will continue for eight more hours. Eleven blood samples will be taken over a 48 hour period.

Project Start
1999-12-01
Project End
2000-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
38
Fiscal Year
2000
Total Cost
$648
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Holkova, Beata; Yazbeck, Victor; Kmieciak, Maciej et al. (2017) A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma. Leuk Lymphoma 58:1349-1357
Corey, Kathleen E; Vuppalanchi, Raj; Vos, Miriam et al. (2015) Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 60:360-7
Eaton, J E; Juran, B D; Atkinson, E J et al. (2015) A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease. Aliment Pharmacol Ther 41:980-90
Worthington Jr, Everett L; Berry, Jack W; Hook, Joshua N et al. (2015) Forgiveness-reconciliation and communication-conflict-resolution interventions versus retested controls in early married couples. J Couns Psychol 62:14-27
Holkova, Beata; Kmieciak, Maciej; Perkins, E Brent et al. (2014) Phase I trial of bortezomib (PS-341; NSC 681239) and ""nonhybrid"" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms. Clin Cancer Res 20:5652-62
Lo, D J; Farris, A B; Song, M et al. (2013) Inhibition of ?v?6 promotes acute renal allograft rejection in nonhuman primates. Am J Transplant 13:3085-93
Jones, Robert; Vuky, Jacqueline; Elliott, Tony et al. (2013) Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer. Invest New Drugs 31:1001-7
Al Hawaj, M A; Martin, E J; Venitz, J et al. (2013) Monitoring rFVIII prophylaxis dosing using global haemostasis assays. Haemophilia 19:409-14
Noureddin, Mazen; Yates, Katherine P; Vaughn, Ivana A et al. (2013) Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology 58:1644-54
Lo, D J; Anderson, D J; Weaver, T A et al. (2013) Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. Am J Transplant 13:320-8

Showing the most recent 10 out of 367 publications